These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 24909079

  • 1. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC, Oliver AG, Markley LD, Cho S, Franzblau SG, Miller MJ.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3493-8. PubMed ID: 24909079
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Lv K, Li L, Wang B, Liu M, Wang B, Shen W, Guo H, Lu Y.
    Eur J Med Chem; 2017 Sep 08; 137():117-125. PubMed ID: 28577507
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A, Srinivasarao S, Khetmalis YM, Kumar BK, Murugesan S, Shetye G, Ma R, Franzblau SG, Sekhar KVGC.
    Toxicol In Vitro; 2021 Aug 08; 74():105137. PubMed ID: 33684466
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L, Sridevi JP, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2016 Jul 01; 26(13):3135-3140. PubMed ID: 27184765
    [Abstract] [Full Text] [Related]

  • 6. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
    Karale UB, Shinde AU, Babar DA, Sangu KG, Vagolu SK, Eruva VK, Jadav SS, Misra S, Dharmarajan S, Rode HB.
    Arch Pharm (Weinheim); 2021 Oct 01; 354(10):e2000419. PubMed ID: 34185337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 1-Methyl-1H-2-imidazo[4,5-b]pyridinecarboxylic acid and some of its derivatives with suspected antituberculotic activity.
    Bukowski L, Janowiec M.
    Pharmazie; 1996 Jan 01; 51(1):27-30. PubMed ID: 8999430
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
    Chhabria MT, Jani MH.
    Eur J Med Chem; 2009 Oct 01; 44(10):3837-44. PubMed ID: 19423196
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK, Lun S, Yun YJ, Langue DY, Jaskula-Dybka M, Flores A, Frazier E, Scurry AC, Zavala A, Arreola KR, Pierzchalski B, Ayitou AJ, Bishai WR.
    Chem Biol Drug Des; 2020 Dec 01; 96(6):1362-1371. PubMed ID: 32515129
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A, Lv K, Li L, Liu H, Tao Z, Wang B, Liu M, Ma C, Ma X, Han B, Wang A, Lu Y.
    Eur J Med Chem; 2019 Sep 15; 178():715-725. PubMed ID: 31229874
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G, Suresha Kumara TH, Nagendrappa G, Sowmya HB, Sriram D, Yogeeswari P, Sridevi JP, Guru Row TN, Hosamani AA, Sujan Ganapathy PS, Chandrika N, Narendra LV.
    Eur J Med Chem; 2015 Jan 07; 89():616-27. PubMed ID: 25462270
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H, Wang A, Gu J, Fu L, Lv K, Ma C, Tao Z, Wang B, Liu M, Guo H, Lu Y.
    Eur J Med Chem; 2019 Mar 01; 165():11-17. PubMed ID: 30654236
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Some reactions of 2-cyanomethylimidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
    Bukowski L, Janowiec M, Zwolska-Kwiek Z, Andrzejczyk Z.
    Pharmazie; 1998 Jun 01; 53(6):373-6. PubMed ID: 9675766
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
    Wang A, Wang H, Geng Y, Fu L, Gu J, Wang B, Lv K, Liu M, Tao Z, Ma C, Lu Y.
    Bioorg Med Chem; 2019 Mar 01; 27(5):813-821. PubMed ID: 30692025
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.